NCT00372177View on ClinicalTrials.gov

The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Rheumatoid ArthritisPolyarthritisRheumatismAutoimmune DiseaseInflammation
Interventions
RADIATION

Fab-fragment of Anti-human CD4

Sterile lyophilized Powder for Preparation of a Solution and sterile labelling Buffer labelling with Tc99m-Pertechnetat Intravenous injection

Trial Locations (1)

04103

Clinic and Policlinic for Nuclear Medicine, Medical faculty, University of Leipzig, Leipzig

All Listed Sponsors
collaborator

Technische Universität Dresden

OTHER

collaborator

University of Leipzig

OTHER

lead

Biotectid GmbH

INDUSTRY

NCT00372177 - The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter